opticeuticals.com
The category authority. The Opticeutical Standard. The consumer-facing reference for optimized nutraceuticals. Audience: partners, journalists, informed consumers.
Opticeuticals is the public reference for the category of optimized nutraceuticals. The category is defined and stewarded by Atumnus Life Sciences.

Opticeuticals exists to name a category that previously had no name, publish a standard that governs membership in it, and maintain that standard as the science and supply-chain practice evolve.
The nutraceutical category became too broad to communicate distinctions within it. A higher-tier subset existed in practice for years before there was a vocabulary for it. The Opticeutical designation supplies that vocabulary, anchored to a published standard that any product can be measured against.
Atumnus Life Sciences is the entity responsible for the definition, governance, and ongoing development of the Opticeutical Standard. Atumnus is positioned in life sciences rather than in any single product vertical. The work spans bioregulator-grounded formulation, intellectual property development, scientific partnerships, and the institutional infrastructure that supports the category as a whole.
The decision to publish the Opticeutical Standard as a public document, rather than as a proprietary certification mark, is deliberate. The category benefits from clarity even when other actors meet the standard. A defined category with multiple qualified producers is more useful, to every stakeholder downstream, than a closed designation governed for competitive advantage.
Atumnus Life Sciences stewards the category. It does not monopolize the category. Multiple organizations can produce Opticeutical-tier products. The standard governs the product, not the maker.
Atumnus Life Sciences holds a portfolio of issued patents, patent-pending applications, and registered and pending trademarks across compositions, formulation, manufacturing, delivery, administration, combination architecture, and proprietary AI infrastructure — every discipline required to bring an Opticeutical to market.
The portfolio is built on a foundation of bioregulator science and protects the trade names visible across the platform portfolio. Qualified partners and capital partners may request access to the intellectual property overview through the contact channel.
Ian is the founder and CEO of Activation Products and a founding-tier principal of Atumnus Life Sciences. Following a 2004 health crisis that he addressed through natural means rather than conventional intervention, Ian spent the next two decades traveling the world to identify potent natural formulations, heritage compounds, and sourcing relationships that conventional supply chains overlook.
His role as Founding Curator anchors the category's discipline of sourcing integrity, natural-formulation discovery, and the institutional knowledge that informs the Opticeutical Standard. The collaboration between Activation Products and Atumnus Life Sciences, announced in 2026, brings that two-decade depth of curation expertise into the founding team of the category authority.
Atumnus Life Sciences maintains distinct reference surfaces for distinct audiences. The category, the science, and the AI infrastructure each have their own canonical home. Together they form the institutional architecture behind the Opticeutical standard.
The category authority. The Opticeutical Standard. The consumer-facing reference for optimized nutraceuticals. Audience: partners, journalists, informed consumers.
The institutional reference for the discipline of endogenic pharmacology, the bioregulator taxonomy, the full research lineage, and the four-layer regenerative model. Audience: researchers, clinicians, policy stakeholders.
Visit referenceThe intellectual and AI infrastructure beneath the Atumnus program — a discipline of artificial intelligence with the human at the center of the work. Documented at the institutional reference.
Read the disciplineThe Opticeutical Standard is published in full and remains accessible to any organization, journalist, or individual wishing to audit it, reference it, or build to it.
Revisions occur on a regular cadence as the underlying science and supply-chain practice evolve. Each revision is published and dated. The standard improves over time without breaking continuity.
Compliance with the standard is verified by independent laboratories, not by the steward. This separation is structural. Atumnus Life Sciences cannot self-certify a product as meeting the standard.
33 long-form appearances spanning 2014–2025.
Manufacturing partners, scientific advisors, journalists, and organizations interested in the standard. Contact opens a direct channel to Atumnus Life Sciences as steward of the category.